No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
REXR240621P40000
- 0.15
- 0.000.00%
15min DelayTrading Jun 10 13:19 ET
0.00High0.00Low
0.00Open0.15Pre Close0 Volume52 Open Interest40.00Strike Price0.00Turnover118.80%IV9.58%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.0927Delta0.0494Gamma293.80Leverage Ratio-0.1415Theta-0.0002Rho-27.24Eff Leverage0.0047Vega
Intraday
- 5D
- Daily
News
Express News | Corrected-Rexford Industrial Realty: Approved Appointment of Laura Clark, CFO of Co & Rexford Industrial Realty, L.p., to Position of COO of Corp & Operating Partnership (Adds Dropped Words)
Rexford Searches for New CFO; Current CFO to Assume New COO Role
Express News | Rexford Industrial Realty Ti Recruit New CFO; Promote CFO Laura Clark To COO
Express News | Rexford Industrial Realty Inc: Approved Appointment of Laura Clark, Chief Financial Officer of Co & Rexford Industrial Realty, L.p.,
Rexford Industrial Realty Plans to Promote Current CFO Laura Clark to New Role of Chief Operating Officer
Rexford Industrial Realty Plans to Promote Current CFO Laura Clark to New Role of Chief Operating Officer
Rexford Industrial Realty Initiated a Process to Recruit a New Chief Fincl Officer >REXR
Rexford Industrial Realty Initiated a Process to Recruit a New Chief Fincl Officer >REXR
Comments
The Co-CEOs of the company, Michael Frankel and Howard Schwimmer, expressed their commitment to driving long-term shareholder value and stated their focus on executing value creation strategies for the benefit of their shareholders.
Press Release: Rexford Industrial Announces 10 Percent Increase in Quarterly Common Stock Dividend
$ArcBest(ARCB.US$ initiated at buy by Jefferies, announced target price at $110.00.
$Saia(SAIA.US$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone(AZO.US$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle(ORCL.US$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings(BILL.US$ was downg...
$Saia(SAIA.US$ initiated at buy by Jefferies, announced targe price at $350.00.
$AutoZone(AZO.US$ was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00.
$Oracle(ORCL.US$ was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00.
$BILL Holdings(BILL.US$ was downg...
16
Upgrades
• $ABM Industries(ABM.US$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp(AMT.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight(CHD.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene(CNC.US$ : Credit Suisse Upgrades to Outperform from...
• $ABM Industries(ABM.US$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp(AMT.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight(CHD.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene(CNC.US$ : Credit Suisse Upgrades to Outperform from...
16
Gainers:
• $Array Technologies(ARRY.US$ +12.87% (also names new CEO)
• $Tufin Software Technologies(TUFN.US$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals(CTXR.US$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics(BTAI.US$ +19.22% (FDA ha...
• $Array Technologies(ARRY.US$ +12.87% (also names new CEO)
• $Tufin Software Technologies(TUFN.US$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals(CTXR.US$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics(BTAI.US$ +19.22% (FDA ha...
20
Read more